Study title:
Kiltie-A-E, Lashford-L-S, Gattamaneni-H-R.
Dr. H.R. Gattamaneni, NHS Trust, Christie Hospital, Wilmslow Road, Manchester M20 9BX, United Kingdom.
Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old.
Medical and Pediatric Oncology {MED-PEDIATR-ONCOL}, 1997, Vol/Iss/Pg. 28/5 (348-354), ISSN: 0098-1532.Kiltie-A-E, Lashford-L-S, Gattamaneni-H-R.
Dr. H.R. Gattamaneni, NHS Trust, Christie Hospital, Wilmslow Road, Manchester M20 9BX, United Kingdom.
Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old.
Medical and Pediatric Oncology {MED-PEDIATR-ONCOL}, 1997, Vol/Iss/Pg. 28/5 (348-354), ISSN: 0098-1532.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|